SEC Form 4 · accession 0001179110-15-003449
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Rothera
Officer — Chief Commercial Officer
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 7:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 23, 2015 | S | 3,000 | $64.72 | D | 0 | D | |
| Common Stock | Feb 23, 2015 | M | 20,000 | $10.85 | A | 20,000 | D | |
| Common StockF3 | Feb 23, 2015 | S | 5,000 | $62.69 | D | 15,000 | D | |
| Common StockF4 | Feb 23, 2015 | S | 5,000 | $63.66 | D | 10,000 | D | |
| Common StockF5 | Feb 23, 2015 | S | 10,000 | $67.84 | D | 0 | D | |
| Common Stock | Feb 24, 2015 | M | 1,000 | $10.85 | A | 1,000 | D | |
| Common Stock | Feb 24, 2015 | S | 1,000 | $67.70 | D | 0 | D | |
| Common Stock | Feb 25, 2015 | M | 10,375 | $10.85 | A | 10,375 | D | |
| Common Stock | Feb 25, 2015 | M | 625 | $10.85 | A | 11,000 | D | |
| Common StockF6 | Feb 25, 2015 | S | 11,000 | $73.49 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F7 | $10.85 | Feb 23, 2015 | M | 20,000 | D | — | May 15, 2023 | Common Stock | 20,000 | 118,000 | D |
| Stock Option (Right To Buy)F7 | $10.85 | Feb 24, 2015 | M | 1,000 | D | — | May 15, 2023 | Common Stock | 1,000 | 117,000 | D |
| Stock Option (Right To Buy)F7 | $10.85 | Feb 25, 2015 | M | 10,375 | D | — | May 15, 2023 | Common Stock | 10,375 | 106,625 | D |
| Stock Option (Right To Buy)F8 | $10.85 | Feb 25, 2015 | M | 625 | D | — | May 15, 2015 | Common Stock | 625 | 9,375 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.30 to $65.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $62.30 to $63.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $63.20 to $64.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.70 to $68.29 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.35 to $73.97 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- F8This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.